Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Mullish

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
The Biochemical Journal|June 5, 2025
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive dataChianna Umamahesan, Aleksandra Pilcicka, Jennifer Yick, et al.
Gut Microbes|May 25, 2019
In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantationBreanna McSweeney, Jessica R Allegretti, Monika Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2020
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant OrganismsRohma Ghani, Benjamin H Mullish, Julie A K McDonald, et al.
ACR Open Rheumatology|September 22, 2023
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA TrialMaja Skov Kragsnaes, Jesus Miguens Blanco, Benjamin H Mullish, et al.
Scientific Reports|January 10, 2023
Rectal swabs as a viable alternative to faecal sampling for the analysis of gut microbiota functionality and compositionShiva T Radhakrishnan, Kate I Gallagher, Benjamin H Mullish, et al.
The Lancet. Gastroenterology & Hepatology|September 18, 2022
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panelGianluca Ianiro, Benjamin H Mullish, Tariq H Iqbal, et al.
The Journal of Hospital Infection|September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2022
Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infectionBenjamin H Mullish, Laura Martinez-Gili, Elena Chekmeneva, et al.
Scandinavian Journal of Gastroenterology|October 2, 2018
Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective studyJonathan P Segal, Lawrence Penez, Soad Mohsen Elkady, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
The Biochemical Journal|June 5, 2025
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive dataChianna Umamahesan, Aleksandra Pilcicka, Jennifer Yick, et al.
Gut Microbes|May 25, 2019
In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantationBreanna McSweeney, Jessica R Allegretti, Monika Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2020
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant OrganismsRohma Ghani, Benjamin H Mullish, Julie A K McDonald, et al.
ACR Open Rheumatology|September 22, 2023
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA TrialMaja Skov Kragsnaes, Jesus Miguens Blanco, Benjamin H Mullish, et al.
Scientific Reports|January 10, 2023
Rectal swabs as a viable alternative to faecal sampling for the analysis of gut microbiota functionality and compositionShiva T Radhakrishnan, Kate I Gallagher, Benjamin H Mullish, et al.
The Lancet. Gastroenterology & Hepatology|September 18, 2022
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panelGianluca Ianiro, Benjamin H Mullish, Tariq H Iqbal, et al.
The Journal of Hospital Infection|September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2022
Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infectionBenjamin H Mullish, Laura Martinez-Gili, Elena Chekmeneva, et al.
Scandinavian Journal of Gastroenterology|October 2, 2018
Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective studyJonathan P Segal, Lawrence Penez, Soad Mohsen Elkady, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
Pageof 15